<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00919126</url>
  </required_header>
  <id_info>
    <org_study_id>ALMED-07-C3-007</org_study_id>
    <secondary_id>2007-001979-10</secondary_id>
    <nct_id>NCT00919126</nct_id>
  </id_info>
  <brief_title>General Anesthesia With Xenon in Inspiratory Concentrations of 50% and 70% and Total I.V. Anaesthesia.</brief_title>
  <official_title>An International Phase III Randomised Trial Comparing the Propofol Consumption During General Anaesthesia With Xenon in Inspiratory Concentrations of 50% and 70% and Total I.V. Anaesthesia Alone in ASA III Patients With Increased Risk of Perioperative Cardiac Complications.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Air Liquide SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Air Liquide SA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the quantity of propofol administered with Xenon in
      two inspiratory concentrations, to maintain comparable depth of anaesthesia during the
      maintenance period of general anaesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The inert or &quot;noble&quot; gas Xenon has anaesthetic properties that have been recognized 50 years
      ago. Several preclinical studies and investigations using xenon as an inhalational
      anaesthetic in humans were performed and reported that this gas has many properties of the
      ideal anaesthetic agent. Moreover, it is known that when xenon is combined with volatile
      anaesthetics or opioids, the required doses of those substances are reduced, resulting in a
      lower incidence of side effects. Patients could benefit from the administration of xenon if
      this inspired concentration would result in reduced doses of co-administered drugs.

      This trial should allow evaluating the propofol consumption required in combination with
      xenon administered in inspiratory concentrations of 50% and 70% to maintain comparable depth
      of general anaesthesia as total i.v. anaesthesia, in ASA III patients presenting increased
      risk of perioperative cardiac complications and undergoing laparotomy or orthopaedic surgery.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Enrollment rate
  </why_stopped>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dose of Propofol (mg) Administered During Maintenance Adjusted to Patient Body Surface Area (BSA in m²) and Maintenance Duration (Min)</measure>
    <time_frame>Maintenance period (1 Day)</time_frame>
    <description>Dose of propofol administered with a Target Controlled Infusion (TCI) device, cerebral concentration equal to 5 µg/mL at the end of induction, and then concentration adjusted to the level of depth of anaesthesia during maintenance. Depth of anaesthesia continuously assessed by signals derived from electroencephalographic recording. Analgesia during induction and maintenance obtained with remifentanil administered with a second TCI device at the stable cerebral concentration of 7 ng/mL.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anaesthesia Recovery Time</measure>
    <time_frame>1 Postoperative Day</time_frame>
    <description>Time interval between the end of maintenance period and time of tracheal tube removal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Awakening Time</measure>
    <time_frame>1 Postoperative Day</time_frame>
    <description>Time interval between the end of maintenance period and time of Aldrete score ≥ 9.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stay in the Operating Room</measure>
    <time_frame>1 Postoperative Day</time_frame>
    <description>Time interval between admission in the operating room and discharge from the operating room.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stay in the Recovery Room</measure>
    <time_frame>1 Postoperative Day</time_frame>
    <description>Time interval between admission in the recovery room and discharge from the recovery room.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haematology - Leucocytes (Giga/L)</measure>
    <time_frame>1 Postoperative Day</time_frame>
    <description>Leucocytes (Giga/L) obtained from blood samples collected at baseline and in the morning following surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haematology - Erythrocytes (Tera/L)</measure>
    <time_frame>1 Postoperative Day.</time_frame>
    <description>Erythrocytes (Tera/L) obtained from blood samples collected at baseline and in the morning following surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haematology - Platelets (Giga/L)</measure>
    <time_frame>1 Postoperative Day</time_frame>
    <description>Platelets (Giga/L) obtained from blood samples collected at baseline and in the morning following surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry - AST (GOT) (IU/L)</measure>
    <time_frame>1 Postoperative Day</time_frame>
    <description>AST (GOT) (IU/L) obtained from blood samples collected at baseline and in Morning following surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry - ALT (GPT) (IU/L)</measure>
    <time_frame>1 Postoperative Day</time_frame>
    <description>ALT (GPT) (IU/L) obtained from blood samples collected at baseline and in Morning following surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry - Gamma GT (IU/L)</measure>
    <time_frame>1 Postoperative Day</time_frame>
    <description>Gamma GT (IU/L) obtained from blood samples collected at baseline and in Morning following surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry - Creatinine (Mcmol/L)</measure>
    <time_frame>1 Postoperative Day</time_frame>
    <description>Creatinine (mcmol/L) obtained from blood samples collected at baseline and in Morning following surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry - Urea (mmol/L)</measure>
    <time_frame>1 Postoperative Day</time_frame>
    <description>Urea (mmol/L) obtained from blood samples collected at baseline and in Morning following surgery</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Anaesthesia</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Xenon 50% (45%-55%) in Oxygen (45%-55%),</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Medical Air in Oxygen (45%-55%)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xenon</intervention_name>
    <description>Maintenance of anaesthesia obtained with Xenon 50% and propofol infusion adjusted to depth of anaesthesia.</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xenon</intervention_name>
    <description>Maintenance of anaesthesia obtained with Xenon 70% and propofol infusion adjusted to depth of anaesthesia.</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Medical Air in Oxygen</intervention_name>
    <description>Maintenance of anaesthesia obtained with propofol infusion adjusted to depth of anaesthesia.</description>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient ≥ 50 years old

          -  ASA (American Society of Anaesthesiologists) Physical Status III

          -  Patient with increased risk of perioperative cardiac complications (Revised Cardiac
             Risk Index&gt;=2)

          -  Surgical operation: laparotomy or orthopaedic surgery or laparoscopy

          -  Planned duration of general anaesthesia in the range of 2-6 hours

          -  Patient willing and able to complete the requirements of this study including the
             signature of the written informed consent

        Exclusion Criteria:

          -  Patient with severe impairment of cardiac function (Left Ventricular Ejection Fraction
             &lt; 35%)

          -  Patient with drug-eluting stent placed within 12 months prior to selection

          -  Woman of child-bearing potential not implementing adequate contraceptive methods

          -  Pregnant or lactating woman

          -  Surgical procedure in emergency

          -  Chronic opioids pain therapy

          -  Serious illness or medical conditions which are possible contra indication for
             elective general anaesthesia or administration of intra operative treatments, or which
             are interfering with the monitoring devices, such as:

               -  Myocardial infarction within 6 months prior to selection

               -  Any significant history of allergy/hypersensitivity to any drugs used during the
                  study, to silicone or to latex

               -  Severely impaired hearing

               -  Known severe neurological disorders

               -  Any medical condition which does not justify the trial participation in the
                  investigator's judgement

               -  General anaesthesia within 7 days prior to selection

               -  Laparotomy within 3 months prior to selection, only for patients undergoing
                  laparotomy

          -  History of drug abuse or psychiatric disorders which would impair the understanding of
             the necessary information or render medically or legally not able to give written
             informed consent

          -  Concurrent treatment with any other experimental drugs

          -  Participation in any other clinical trial within 4 weeks prior to selection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Berthold BEIN, Prof Dr Med</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Schleswig-Holstein</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jens SCHOLZ, Prof. Dr Med</last_name>
    <role>Study Chair</role>
    <affiliation>University of Schleswig-Holstein</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63058</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Universitaire Caremeau</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Waldkrankenhaus Berlin-Spandau</name>
      <address>
        <city>Berlin</city>
        <zip>D-14129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BG Kliniken-Bergmannstrost</name>
      <address>
        <city>Halle</city>
        <zip>D-06112</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <zip>D-24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manchester Royal Infirmary</name>
      <address>
        <city>Manchester</city>
        <zip>M139WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2009</study_first_submitted>
  <study_first_submitted_qc>June 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2009</study_first_posted>
  <results_first_submitted>June 4, 2014</results_first_submitted>
  <results_first_submitted_qc>June 18, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 17, 2014</results_first_posted>
  <last_update_submitted>September 15, 2014</last_update_submitted>
  <last_update_submitted_qc>September 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Xenon in Anaesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Xenon</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Group A</title>
          <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
        </group>
        <group group_id="P2">
          <title>Group B</title>
          <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
        </group>
        <group group_id="P3">
          <title>Group C</title>
          <description>Medical Air in Oxygen (45%-55%)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="37"/>
                <participants group_id="P3" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The analysis was done in the Intention To Treat (ITT) Data Set (Randomised Patients).</population>
      <group_list>
        <group group_id="B1">
          <title>Group A</title>
          <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
        </group>
        <group group_id="B2">
          <title>Group B</title>
          <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
        </group>
        <group group_id="B3">
          <title>Group C</title>
          <description>Medical Air in Oxygen (45%-55%)</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
            <count group_id="B2" value="37"/>
            <count group_id="B3" value="33"/>
            <count group_id="B4" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.8" spread="8.2"/>
                    <measurement group_id="B2" value="70.0" spread="9.7"/>
                    <measurement group_id="B3" value="71.1" spread="6.9"/>
                    <measurement group_id="B4" value="70.3" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81.18" spread="17.39"/>
                    <measurement group_id="B2" value="80.41" spread="19.61"/>
                    <measurement group_id="B3" value="81.12" spread="16.74"/>
                    <measurement group_id="B4" value="80.88" spread="17.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="168.4" spread="8.8"/>
                    <measurement group_id="B2" value="168.0" spread="8.9"/>
                    <measurement group_id="B3" value="169.2" spread="9.8"/>
                    <measurement group_id="B4" value="168.5" spread="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Surface Area</title>
          <units>m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.938" spread="0.228"/>
                    <measurement group_id="B2" value="1.926" spread="0.251"/>
                    <measurement group_id="B3" value="1.943" spread="0.228"/>
                    <measurement group_id="B4" value="1.935" spread="0.235"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>Kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.71" spread="6.26"/>
                    <measurement group_id="B2" value="28.43" spread="6.09"/>
                    <measurement group_id="B3" value="28.39" spread="5.98"/>
                    <measurement group_id="B4" value="28.51" spread="6.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Planned High-Risk Surgical Procedures</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of Ischemic Heart Disease</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of Congestive Heart Failure</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of Cerebrovascular Disease</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-Operative Treatment With Insulin or Antidiabetics</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-Operative Serum Creatinine &gt;2.0 mg/dL</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Dose of Propofol (mg) Administered During Maintenance Adjusted to Patient Body Surface Area (BSA in m²) and Maintenance Duration (Min)</title>
        <description>Dose of propofol administered with a Target Controlled Infusion (TCI) device, cerebral concentration equal to 5 µg/mL at the end of induction, and then concentration adjusted to the level of depth of anaesthesia during maintenance. Depth of anaesthesia continuously assessed by signals derived from electroencephalographic recording. Analgesia during induction and maintenance obtained with remifentanil administered with a second TCI device at the stable cerebral concentration of 7 ng/mL.</description>
        <time_frame>Maintenance period (1 Day)</time_frame>
        <population>The main analysis was done in the ITT Data Set (Randomised Patients).</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70%(65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Dose of Propofol (mg) Administered During Maintenance Adjusted to Patient Body Surface Area (BSA in m²) and Maintenance Duration (Min)</title>
          <description>Dose of propofol administered with a Target Controlled Infusion (TCI) device, cerebral concentration equal to 5 µg/mL at the end of induction, and then concentration adjusted to the level of depth of anaesthesia during maintenance. Depth of anaesthesia continuously assessed by signals derived from electroencephalographic recording. Analgesia during induction and maintenance obtained with remifentanil administered with a second TCI device at the stable cerebral concentration of 7 ng/mL.</description>
          <population>The main analysis was done in the ITT Data Set (Randomised Patients).</population>
          <units>mg adjusted</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.683" spread="0.834"/>
                    <measurement group_id="O2" value="1.005" spread="1.121"/>
                    <measurement group_id="O3" value="3.987" spread="1.431"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The dose of propofol adjusted to BSA and maintenance duration was expected to be 4.0 mg/m².min in the control group, 2.8 mg/m².min in one xenon group and 3.0 mg/m².min in the other xenon group. With an expected common standard deviation of 2.0 mg/m².min, a type I error of 0.05 (two-sided) and a power of 0.80, the sample size required to show a statistically significant difference between the three groups was estimated to be 48 patients per group, resulting in a total of 144 randomised patients.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>ANCOVA</method>
            <method_desc>The analysis of covariance was adjusted for quantity of propofol (mg) administered during the induction period, gender, type of surgery and centre.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Pairwise comparison performed using Tukey’s test.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>The analysis of covariance was adjusted for quantity of propofol (mg) administered during the induction period, gender, type of surgery and centre.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>3.0256</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.328</ci_lower_limit>
            <ci_upper_limit>3.724</ci_upper_limit>
            <estimate_desc>The difference Xenon 70% in Oxygen minus Medical Air in Oxygen was assessed.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Pairwise comparison performed using Tukey’s test.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>The analysis of covariance was adjusted for quantity of propofol (mg) administered during the induction period, gender, type of surgery and centre.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>2.2905</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.570</ci_lower_limit>
            <ci_upper_limit>3.011</ci_upper_limit>
            <estimate_desc>The difference Xenon 50% in Oxygen minus Medical Air in Oxygen was assessed.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0365</p_value>
            <p_value_desc>Pairwise comparison was performed using the Tukey's test.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>The analysis of covariance was adjusted for quantity of propofol (mg) administered during the induction period, gender, type of surgery and centre.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.7351</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.038</ci_lower_limit>
            <ci_upper_limit>1.432</ci_upper_limit>
            <estimate_desc>The difference Xenon 70% in Oxygen minus Xenon 50% in Oxygen was assessed</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Anaesthesia Recovery Time</title>
        <description>Time interval between the end of maintenance period and time of tracheal tube removal.</description>
        <time_frame>1 Postoperative Day</time_frame>
        <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70%(65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Anaesthesia Recovery Time</title>
          <description>Time interval between the end of maintenance period and time of tracheal tube removal.</description>
          <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="35"/>
                <count group_id="O3" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.3" spread="15.8"/>
                    <measurement group_id="O2" value="22.2" spread="62.6"/>
                    <measurement group_id="O3" value="43.3" spread="180.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Awakening Time</title>
        <description>Time interval between the end of maintenance period and time of Aldrete score ≥ 9.</description>
        <time_frame>1 Postoperative Day</time_frame>
        <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Awakening Time</title>
          <description>Time interval between the end of maintenance period and time of Aldrete score ≥ 9.</description>
          <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.9" spread="37.6"/>
                    <measurement group_id="O2" value="70.7" spread="74.2"/>
                    <measurement group_id="O3" value="62.6" spread="34.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stay in the Operating Room</title>
        <description>Time interval between admission in the operating room and discharge from the operating room.</description>
        <time_frame>1 Postoperative Day</time_frame>
        <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Stay in the Operating Room</title>
          <description>Time interval between admission in the operating room and discharge from the operating room.</description>
          <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="37"/>
                <count group_id="O3" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="273.1" spread="115.5"/>
                    <measurement group_id="O2" value="288.2" spread="119.1"/>
                    <measurement group_id="O3" value="315.0" spread="141.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stay in the Recovery Room</title>
        <description>Time interval between admission in the recovery room and discharge from the recovery room.</description>
        <time_frame>1 Postoperative Day</time_frame>
        <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Stay in the Recovery Room</title>
          <description>Time interval between admission in the recovery room and discharge from the recovery room.</description>
          <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="187.5" spread="156.3"/>
                    <measurement group_id="O2" value="180.7" spread="132.0"/>
                    <measurement group_id="O3" value="218.0" spread="243.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Haematology - Leucocytes (Giga/L)</title>
        <description>Leucocytes (Giga/L) obtained from blood samples collected at baseline and in the morning following surgery.</description>
        <time_frame>1 Postoperative Day</time_frame>
        <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Haematology - Leucocytes (Giga/L)</title>
          <description>Leucocytes (Giga/L) obtained from blood samples collected at baseline and in the morning following surgery.</description>
          <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
          <units>Giga/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before Anaesthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.118" spread="2.289"/>
                    <measurement group_id="O2" value="8.301" spread="2.980"/>
                    <measurement group_id="O3" value="7.432" spread="1.641"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Morning Following Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.429" spread="2.737"/>
                    <measurement group_id="O2" value="11.574" spread="4.438"/>
                    <measurement group_id="O3" value="11.280" spread="2.818"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Haematology - Erythrocytes (Tera/L)</title>
        <description>Erythrocytes (Tera/L) obtained from blood samples collected at baseline and in the morning following surgery.</description>
        <time_frame>1 Postoperative Day.</time_frame>
        <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Haematology - Erythrocytes (Tera/L)</title>
          <description>Erythrocytes (Tera/L) obtained from blood samples collected at baseline and in the morning following surgery.</description>
          <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
          <units>Tera/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before Anaesthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.373" spread="0.553"/>
                    <measurement group_id="O2" value="4.219" spread="0.798"/>
                    <measurement group_id="O3" value="4.135" spread="0.450"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Morning Following Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.690" spread="0.529"/>
                    <measurement group_id="O2" value="3.763" spread="0.524"/>
                    <measurement group_id="O3" value="3.675" spread="0.564"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Haematology - Platelets (Giga/L)</title>
        <description>Platelets (Giga/L) obtained from blood samples collected at baseline and in the morning following surgery</description>
        <time_frame>1 Postoperative Day</time_frame>
        <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Haematology - Platelets (Giga/L)</title>
          <description>Platelets (Giga/L) obtained from blood samples collected at baseline and in the morning following surgery</description>
          <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
          <units>Giga/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before Anaesthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="225.036" spread="89.556"/>
                    <measurement group_id="O2" value="244.656" spread="71.724"/>
                    <measurement group_id="O3" value="244.214" spread="80.484"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Morning Following Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="188.036" spread="79.083"/>
                    <measurement group_id="O2" value="212.594" spread="79.424"/>
                    <measurement group_id="O3" value="196.250" spread="86.871"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry - AST (GOT) (IU/L)</title>
        <description>AST (GOT) (IU/L) obtained from blood samples collected at baseline and in Morning following surgery.</description>
        <time_frame>1 Postoperative Day</time_frame>
        <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry - AST (GOT) (IU/L)</title>
          <description>AST (GOT) (IU/L) obtained from blood samples collected at baseline and in Morning following surgery.</description>
          <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
          <units>IU/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before Anaesthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.641" spread="32.661"/>
                    <measurement group_id="O2" value="31.926" spread="25.495"/>
                    <measurement group_id="O3" value="30.544" spread="27.369"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Morning Following Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.723" spread="66.482"/>
                    <measurement group_id="O2" value="139.163" spread="420.704"/>
                    <measurement group_id="O3" value="62.348" spread="65.231"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry - ALT (GPT) (IU/L)</title>
        <description>ALT (GPT) (IU/L) obtained from blood samples collected at baseline and in Morning following surgery</description>
        <time_frame>1 Postoperative Day</time_frame>
        <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry - ALT (GPT) (IU/L)</title>
          <description>ALT (GPT) (IU/L) obtained from blood samples collected at baseline and in Morning following surgery</description>
          <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
          <units>IU/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before Anaesthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.498" spread="31.981"/>
                    <measurement group_id="O2" value="24.400" spread="13.176"/>
                    <measurement group_id="O3" value="28.655" spread="27.587"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Morning Following Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.634" spread="111.748"/>
                    <measurement group_id="O2" value="81.747" spread="197.209"/>
                    <measurement group_id="O3" value="48.115" spread="57.414"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry - Gamma GT (IU/L)</title>
        <description>Gamma GT (IU/L) obtained from blood samples collected at baseline and in Morning following surgery</description>
        <time_frame>1 Postoperative Day</time_frame>
        <population>The analysis was done in the ITT Data Set (Randomised Patients)</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry - Gamma GT (IU/L)</title>
          <description>Gamma GT (IU/L) obtained from blood samples collected at baseline and in Morning following surgery</description>
          <population>The analysis was done in the ITT Data Set (Randomised Patients)</population>
          <units>IU/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before Anaesthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122.689" spread="335.374"/>
                    <measurement group_id="O2" value="77.012" spread="80.051"/>
                    <measurement group_id="O3" value="136.785" spread="370.826"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Morning Following Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106.234" spread="198.074"/>
                    <measurement group_id="O2" value="73.021" spread="86.695"/>
                    <measurement group_id="O3" value="90.345" spread="189.828"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry - Creatinine (Mcmol/L)</title>
        <description>Creatinine (mcmol/L) obtained from blood samples collected at baseline and in Morning following surgery</description>
        <time_frame>1 Postoperative Day</time_frame>
        <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry - Creatinine (Mcmol/L)</title>
          <description>Creatinine (mcmol/L) obtained from blood samples collected at baseline and in Morning following surgery</description>
          <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
          <units>mcmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before Anaesthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.625" spread="66.513"/>
                    <measurement group_id="O2" value="106.825" spread="68.814"/>
                    <measurement group_id="O3" value="98.830" spread="40.639"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Morning Following Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115.007" spread="144.682"/>
                    <measurement group_id="O2" value="102.071" spread="61.185"/>
                    <measurement group_id="O3" value="96.273" spread="38.996"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry - Urea (mmol/L)</title>
        <description>Urea (mmol/L) obtained from blood samples collected at baseline and in Morning following surgery</description>
        <time_frame>1 Postoperative Day</time_frame>
        <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
        <group_list>
          <group group_id="O1">
            <title>Group A</title>
            <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
          </group>
          <group group_id="O2">
            <title>Group B</title>
            <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
          </group>
          <group group_id="O3">
            <title>Group C</title>
            <description>Medical Air in Oxygen (45%-55%)</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry - Urea (mmol/L)</title>
          <description>Urea (mmol/L) obtained from blood samples collected at baseline and in Morning following surgery</description>
          <population>The analysis was done in the ITT Data Set (Randomised Patients).</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before Anaesthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.453" spread="4.623"/>
                    <measurement group_id="O2" value="8.680" spread="5.882"/>
                    <measurement group_id="O3" value="7.886" spread="3.087"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Morning Following Surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.317" spread="5.458"/>
                    <measurement group_id="O2" value="7.964" spread="4.404"/>
                    <measurement group_id="O3" value="7.609" spread="2.876"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse Events observed between the onset of induction and the study end</time_frame>
      <desc>Participants at risk are the patients from the ITT Data Set (Randomised Patients).</desc>
      <group_list>
        <group group_id="E1">
          <title>Group A</title>
          <description>Xenon 50% (45%-55%) in Oxygen (45%-55%)</description>
        </group>
        <group group_id="E2">
          <title>Group B</title>
          <description>Xenon 70% (65%-75%) in Oxygen (25%-35%)</description>
        </group>
        <group group_id="E3">
          <title>Group C</title>
          <description>Medical Air in Oxygen (45%-55%)</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Megacolon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Multi-organ Failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatobiliary Disorders</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Necrotising Fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Septic Shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Post Procedural Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Wound Decomposition</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Anastomotic Leak</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Wound Dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Abdominal Wound Dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Oxygen Saturation Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>PO2 Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Confusional State</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="32" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Hyperthermia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Procedural Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Procedural Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Anaesthetic Complication Cardiac</sub_title>
                <description>corresponds to 1 event of &quot;intraoperative bradycardia&quot;</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Post Procedural Complication</sub_title>
                <description>Corresponds to 1 event of &quot;CK rise post-operatively&quot; (Xenon 70%group), 1 event of &quot;slow to breathe deeply post-operatively&quot; (Xenon 70% group) and 1 event of &quot;post-operative bradycardia&quot; (Medical Air group)</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Procedural Nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Anaemia Postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Myoglobin Blood Increased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Blood Creatine Phosphokinase Increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>White Blood Cell Count Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Aspartate Aminotransferase Increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Haematocrit Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Platelet Count Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Troponin T Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Confusional State</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Oliguria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="37"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study has been terminated earlier due to difficulties to find patients meeting the inclusion criteria.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Prof. Dr. Med Berthold BEIN</name_or_title>
      <organization>University Hospital Schleswig-Holstein</organization>
      <phone>+49(0)431-5973 739</phone>
      <email>bein@anasthesie.uni-kiel.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

